Robert Deans

12.4k total citations · 3 hit papers
100 papers, 8.1k citations indexed

About

Robert Deans is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Robert Deans has authored 100 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Genetics, 40 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Robert Deans's work include Mesenchymal stem cell research (53 papers), Tissue Engineering and Regenerative Medicine (13 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Robert Deans is often cited by papers focused on Mesenchymal stem cell research (53 papers), Tissue Engineering and Regenerative Medicine (13 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Robert Deans collaborates with scholars based in United States, United Kingdom and Belgium. Robert Deans's co-authors include Annemarie Moseley, Amelia Bartholomew, Kevin R. McIntosh, Karen Ferrer, Cord Sturgeon, Ronald Hoffman, Sheila Patil, David S. Ucker, Steve Devine and Alan W. Flake and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Circulation.

In The Last Decade

Robert Deans

99 papers receiving 7.8k citations

Hit Papers

Mesenchymal stem cells suppress lymphocyte proliferation ... 2000 2026 2008 2017 2002 2000 2000 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Deans United States 38 5.2k 2.7k 2.4k 814 805 100 8.1k
Luc Sensebé France 45 5.3k 1.0× 2.9k 1.0× 2.6k 1.1× 854 1.0× 815 1.0× 131 8.7k
Philippe Bourin France 40 4.6k 0.9× 2.7k 1.0× 2.1k 0.9× 954 1.2× 842 1.0× 84 8.0k
Pierre Charbord France 45 3.8k 0.7× 1.8k 0.7× 2.6k 1.1× 735 0.9× 1.3k 1.7× 147 7.9k
Dirk Strunk Austria 42 2.6k 0.5× 1.6k 0.6× 2.2k 0.9× 528 0.6× 757 0.9× 121 5.8k
Peiman Hematti United States 46 2.4k 0.5× 1.5k 0.5× 2.7k 1.1× 515 0.6× 951 1.2× 207 6.8k
Mauro Krampera Italy 47 6.7k 1.3× 3.3k 1.2× 3.3k 1.4× 751 0.9× 1.2k 1.5× 160 11.1k
Jérôme Larghero France 45 1.8k 0.3× 2.1k 0.8× 3.3k 1.4× 889 1.1× 1.6k 2.0× 198 7.2k
Ryang Hwa Lee United States 28 4.4k 0.8× 2.5k 0.9× 2.6k 1.1× 708 0.9× 173 0.2× 46 7.2k
Volker Eckstein Germany 37 2.9k 0.6× 1.3k 0.5× 2.2k 0.9× 419 0.5× 1.4k 1.7× 121 6.4k
Jan A. Nolta United States 59 3.9k 0.8× 2.4k 0.9× 5.9k 2.4× 790 1.0× 1.3k 1.6× 233 11.6k

Countries citing papers authored by Robert Deans

Since Specialization
Citations

This map shows the geographic impact of Robert Deans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Deans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Deans more than expected).

Fields of papers citing papers by Robert Deans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Deans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Deans. The network helps show where Robert Deans may publish in the future.

Co-authorship network of co-authors of Robert Deans

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Deans. A scholar is included among the top collaborators of Robert Deans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Deans. Robert Deans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, Andrew, Shanmuga Sozhamannan, Stephanie A Richard, et al.. (2024). Performance of rapid antigen tests to detect SARS-CoV-2 variant diversity and correlation with viral culture positivity: implication for diagnostic development and future public health strategies. mBio. 15(12). e0273724–e0273724. 1 indexed citations
2.
Walish, Joseph J., et al.. (2022). Halo—A Universal Fluorescence Reader Based Threat Agent Detection Platform—A Proof of Concept Study Using SARS-CoV-2 Assays. Frontiers in Public Health. 10. 852083–852083. 2 indexed citations
3.
Deans, Robert. (2021). Engineering Biology—Accelerating Translation. Genetic Engineering & Biotechnology News. 41(1). 44–45, 50.
4.
Ravanidis, Stylianos, Jeroen F. J. Bogie, Robert Deans, et al.. (2017). Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells. Stem Cells International. 2017. 1–16. 4 indexed citations
5.
Bond, Raymond, Dewar Finlay, James McLaughlin, et al.. (2016). Human factors analysis of the CardioQuick Patch®: A novel engineering solution to the problem of electrode misplacement during 12-lead electrocardiogram acquisition. Journal of Electrocardiology. 49(6). 911–918. 12 indexed citations
6.
Soeder, Yorick, Martin Loss, Christian L. Johnson, et al.. (2015). First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation. Stem Cells Translational Medicine. 4(8). 899–904. 47 indexed citations
7.
Deans, Robert, Kurt C. Gunter, Massimo Dominici, & Miguel Forte. (2015). Part 5: Unproven cell therapies and the commercialization of cell-based products. Cytotherapy. 18(1). 138–142. 7 indexed citations
8.
Andrews, Peter W., Joy Cavagnaro, Robert Deans, et al.. (2014). Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nature Biotechnology. 32(8). 724–726. 44 indexed citations
9.
Vaes, Bart, et al.. (2014). Culturing Protocols for Human Multipotent Adult Stem Cells. Methods in molecular biology. 1235. 49–58. 5 indexed citations
10.
Maziarz, Richard T., Timothy Devos, Carlos Bachier, et al.. (2014). Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial. Biology of Blood and Marrow Transplantation. 21(4). 720–728. 44 indexed citations
11.
Savitz, Sean I., et al.. (2011). Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke. 42(3). 825–829. 200 indexed citations
12.
Mays, Robert W., Cesar V. Borlongan, Takao Yasuhara, et al.. (2010). Development of an allogeneic adherent stem cell therapy for treatment of ischemic stroke. 3(1). 2 indexed citations
13.
Boozer, Sherry, Nicholas Lehman, Uma Lakshmipathy, et al.. (2009). Global Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell.. PubMed. 4(1). 17–28. 47 indexed citations
14.
Auletta, Jeffery J., Kenneth R. Cooke, Luis A. Solchaga, Robert Deans, & Wouter Van’t Hof. (2009). Regenerative Stromal Cell Therapy in Allogeneic Hematopoietic Stem Cell Transplantation: Current Impact and Future Directions. Biology of Blood and Marrow Transplantation. 16(7). 891–906. 33 indexed citations
15.
Kovacsovics‐Bankowski, Magdalena, Philip R. Streeter, Mark R. Frey, et al.. (2008). Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. Cellular Immunology. 255(1-2). 55–60. 41 indexed citations
16.
Zeng, Lepeng, Qingsong Hu, Xiaohong Wang, et al.. (2007). Bioenergetic and Functional Consequences of Bone Marrow–Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling. Circulation. 115(14). 1866–1875. 202 indexed citations
17.
Moon, Joong Ho, et al.. (2002). Capture and detection of a quencher labeled oligonucleotide by poly(phenylene ethynylene) particles. Chemical Communications. 104–105. 25 indexed citations
18.
Mitchell, Malcolm S., June Kan‐Mitchell, Boris Minev, Carl F. Edman, & Robert Deans. (2000). A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes.. Cancer Research. 60(22). 6448–56. 32 indexed citations
19.
Liechty, Kenneth W., Tippi C. MacKenzie, Aimen F. Shaaban, et al.. (2000). Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Medicine. 6(11). 1282–1286. 950 indexed citations breakdown →
20.
Liu, Xuan, et al.. (2000). Molecular Cloning and Chromosomal Mapping of a Candidate Cytokine Gene Selectively Expressed in Human CD34+ Cells. Genomics. 65(3). 283–292. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026